<DOC>
	<DOCNO>NCT00300482</DOCNO>
	<brief_summary>The purpose study compare safety efficacy fenofibric acid ( ABT-335 ) + rosuvastatin calcium combination therapy ABT-335 rosuvastatin calcium monotherapy subject multiple abnormal lipid level blood .</brief_summary>
	<brief_title>Evaluate Safety Efficacy ABT-335 Combination With Rosuvastatin Calcium Subjects With Multiple Abnormal Lipid Levels Blood</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Fenofibric acid</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Patients mixed dyslipidemia Subjects unstable medical condition medical condition consider inappropriate clinical trial . Patients take certain medication unstable dose specific medication . Women pregnant plan become pregnant woman lactate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Dyslipidemia</keyword>
	<keyword>Coronary Heart Disease</keyword>
	<keyword>Mixed Dyslipidemia</keyword>
</DOC>